+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk?

Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk?

Therapeutic Advances in Cardiovascular Disease 7(1): 41-44

The purpose of this review was to examine statin therapy and the risk for diabetes among adult women using a selective review. The literature contains reports of new-onset diabetes associated with statin use. While many studies do not report sex-specific results, there is evidence indicating the risk to benefit ratio may vary by gender. However, the absolute effects are not clear because women have historically been under-represented in clinical trials. A review of the literature indicates that the cardiovascular benefits of statins appear to outweigh the risk for statin-related diabetes. However, the effect may depend upon baseline diabetes risk, dose, and statin potency. Rigorous, long-term studies focused on the risks and benefits of statins in women are unavailable to sort for gender-specific differences. Until this changes, individualized attention to risk assessment, and strong prevention with lifestyle changes must prevail.

(PDF emailed within 0-6 h: $19.90)

Accession: 036726792

Download citation: RISBibTeXText

PMID: 23238515

DOI: 10.1177/1753944712468499

Related references

Statin use and the risk of developing diabetes. Study confirms a link, but does the risk outweigh the benefits?. Johns Hopkins Medical Letter Health After 50 24(2): 1-2, 2012

There is a slight increase in incident diabetes risk with the use of statins, but benefits likely outweigh any adverse effects in those with moderate-to-high cardiovascular risk. Evidence-Based Medicine 15(3): 84-85, 2010

Statin use linked to increased risk of diabetes in older women. Risk of type 2 diabetes in postmenopausal women may be up to 48 percent higher than in women who do not use the cholesterol-lowering drugs, but the jury tilts in favor of continuing medication. Dukemedicine Healthnews 18(4): 4-5, 2012

Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?. Drug Safety 20(4): 289-297, 1999

Benefits of azathioprine maintenance therapy for Crohns disease outweigh the risk of non-Hodgkins lymphoma. Gastroenterology 116(4 PART 2): A763, 1999

The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter?. Progress in Cardiovascular Diseases 59(2): 145-152, 2016

Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events. Evidence-Based Medicine 17(2): 55-56, 2011

Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes. Indian Journal of Medical Research 138(4): 461-491, 2015

Some oral antidiabetic medications may prevent Type 2 diabetes in people at high risk for it, but the evidence is insufficient to determine whether the potential benefits outweigh the possible risks. Evidence-Based Medicine 17(4): 111-112, 2011

Statin Associated Muscle Symptoms: Does the benefit outweigh the risk factor?. Muscle and Nerve 2019, 2019

Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Archives of Internal Medicine 172(2): 144-152, 2012

Benefits of statin therapy and compliance in high risk cardiovascular patients. Vascular Health and Risk Management 6: 843-853, 2010

Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. Journal of the American College of Cardiology 65(4): 402-404, 2015

Belatacept: Where the BENEFITS Outweigh the Risk. American Journal of Kidney Diseases 69(5): 561-563, 2018

Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes. Diabetologia 52(3): 394-397, 2008